These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
397 related items for PubMed ID: 10696077
1. Peroxisome proliferator-activated receptors in the cardiovascular system. Bishop-Bailey D. Br J Pharmacol; 2000 Mar; 129(5):823-34. PubMed ID: 10696077 [Abstract] [Full Text] [Related]
2. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Marx N, Duez H, Fruchart JC, Staels B. Circ Res; 2004 May 14; 94(9):1168-78. PubMed ID: 15142970 [Abstract] [Full Text] [Related]
3. The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways. Kliewer SA, Lehmann JM, Milburn MV, Willson TM. Recent Prog Horm Res; 1999 May 14; 54():345-67; discussion 367-8. PubMed ID: 10548883 [Abstract] [Full Text] [Related]
4. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Chinetti G, Fruchart JC, Staels B. Inflamm Res; 2000 Oct 14; 49(10):497-505. PubMed ID: 11089900 [Abstract] [Full Text] [Related]
5. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control]. Bocher V, Chinetti G, Fruchart JC, Staels B. J Soc Biol; 2002 Oct 14; 196(1):47-52. PubMed ID: 12134632 [Abstract] [Full Text] [Related]
6. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. Touyz RM, Schiffrin EL. Vascul Pharmacol; 2006 Jul 14; 45(1):19-28. PubMed ID: 16782410 [Abstract] [Full Text] [Related]
8. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy]. Bełtowski J, Wójcicka G, Jamroz A. Postepy Hig Med Dosw; 2003 Jul 14; 57(2):199-217. PubMed ID: 12866356 [Abstract] [Full Text] [Related]
9. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease. Guan Y. Minerva Urol Nefrol; 2002 Jun 14; 54(2):65-79. PubMed ID: 12185990 [Abstract] [Full Text] [Related]
10. Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease. Takano H, Komuro I. J Diabetes Complications; 2002 Jun 14; 16(1):108-14. PubMed ID: 11872377 [Abstract] [Full Text] [Related]
11. Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease. Keller JM, Collet P, Bianchi A, Huin C, Bouillaud-Kremarik P, Becuwe P, Schohn H, Domenjoud L, Dauça M. Int J Dev Biol; 2000 Aug 14; 44(5):429-42. PubMed ID: 11032176 [Abstract] [Full Text] [Related]
12. Peroxisome proliferator-activated receptors and the control of inflammation. Cabrero A, Laguna JC, Vázquez M. Curr Drug Targets Inflamm Allergy; 2002 Sep 14; 1(3):243-8. PubMed ID: 14561188 [Abstract] [Full Text] [Related]
13. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall. Chinetti G, Fruchart JC, Staels B. Z Kardiol; 2001 Sep 14; 90 Suppl 3():125-32. PubMed ID: 11374025 [Abstract] [Full Text] [Related]
15. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro. Downie MM, Sanders DA, Maier LM, Stock DM, Kealey T. Br J Dermatol; 2004 Oct 14; 151(4):766-75. PubMed ID: 15491415 [Abstract] [Full Text] [Related]